Search results for "Heart Valve Prosthesi"

showing 10 items of 66 documents

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - R…

2019

Background and aim: The number of percutaneous edge-to-edge mitral regurgitation (MR) valve repairs with MitraClip® implantations increased exponentially in recent years. Studies have suggested an obesity survival paradox in patients with cardiovascular diseases. We investigated the influence of obesity on adverse in-hospital outcomes in patients with MitraClip® implantation. Methods and results: We analyzed data on characteristics of patients and in-hospital outcomes for all percutaneous mitral valve repairs using the edge-to-edge MitraClip®-technique in Germany 2011–2015 stratified for obesity vs. normal-weight/over-weight. The nationwide inpatient sample comprised 13,563 inpatients under…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsDatabases FactualEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyProsthesis DesignRisk Assessment03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsGermanyInternal medicineMitral valvemedicineHumansHospital MortalityObesityAgedAged 80 and overHeart Valve Prosthesis ImplantationMechanical ventilationMitral regurgitationNutrition and Dieteticsbusiness.industryMitraClipMitral Valve Insufficiencymedicine.diseasePulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisHeart failureCardiologyFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessObesity paradoxNutrition, Metabolism and Cardiovascular Diseases
researchProduct

12‐Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation

2021

Objectives We investigated the durability of tricuspid regurgitation (TR) reduction and the clinical outcomes through 12 months after transcatheter tricuspid valve repair (TTVr) with the PASCAL Transcatheter Valve Repair System. Background TTVr has rapidly developed and demonstrated favorable acute outcomes, but longer follow-up data are needed. Methods Overall, 30 patients (age 77 ± 6 years; 57% female) received PASCAL implantation from September 2017 to May 2019 and completed a clinical follow-up at 12 months. Results The TR etiology was functional in 25 patients (83%), degenerative in three (10%), and mixed in two (7%). All patients had TR severe or greater (massive or torrential in 80%)…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsRegurgitation (circulation)030204 cardiovascular system & hematologytranscatheter tricuspid valve intervention PASCAL 12-month outcomes severe tricuspid regurgitation right-sided heart failure03 medical and health sciences0302 clinical medicinemedicineHumansEndocarditisRadiology Nuclear Medicine and imagingddc:610030212 general & internal medicineTRICUSPID VALVE REPAIRStrokeSurvival rateAgedAged 80 and overHeart Valve Prosthesis Implantationbusiness.industryPascal (unit)General Medicinemedicine.diseaseTricuspid Valve InsufficiencySurgeryTreatment OutcomeHeart failureEtiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Interventions
researchProduct

Predictors of short‐ and long‐term outcomes of patients undergoing transcatheter mitral valve edge‐to‐edge repair

2020

Objectives Transcatheter mitral valve repair (TMVR) by edge-to-edge therapy is an established treatment for severe mitral valve regurgitation (MR). Background Symptomatic and prognostic benefit in functional MR has been shown recently; nevertheless, data on long-term outcomes are sparse. Methods and results We analyzed survival of patients treated with isolated edge-to-edge repair from June 2010 to March 2018 (primarily combined edge-to-edge repair with other mitral valve interventions was excluded) in a retrospective monocentric study. Overall, 627 consecutive patients (47.0% females, 78.6 years in mean) were included. Leading etiology was functional MR (57.4%). Follow-up regarding surviva…

MaleCardiac Catheterizationmedicine.medical_specialtymedicine.medical_treatmentDischarged alive030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineMitral valveLong term outcomesmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineRetrospective StudiesHeart Valve Prosthesis ImplantationCOPDMitral valve repairMitral regurgitationbusiness.industryMitral Valve InsufficiencyGeneral Medicinemedicine.diseaseSurgeryTreatment Outcomemedicine.anatomical_structureEtiologyMitral ValveFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessCatheterization and Cardiovascular Interventions
researchProduct

A Comparison of 2 Mitral Annuloplasty Rings for Severe Ischemic Mitral Regurgitation: Clinical and Echocardiographic Outcomes.

2016

Controversies regarding the choice of annuloplasty rings for treatment of ischemic mitral regurgitation still exist. Aim of the study is to compare early performance of 2 different rings in terms of rest and exercise echocardiographic parameters (transmitral gradient, systolic pulmonary artery pressure, and mitral valve area), clinical outcomes, and recurrence of mitral regurgitation. From January 2008 till December 2013, prospectively collected data of patients who underwent coronary artery bypass grafting and undersizing mitral valve annuloplasty for severe chronic ischemic mitral regurgitation at our Institution were reviewed. A total of 93 patients were identified; among them 44 had sem…

MaleMitral Valve AnnuloplastyTime FactorsMyocardial IschemiaHemodynamics030204 cardiovascular system & hematologySeverity of Illness IndexVentricular Function Left0302 clinical medicinePostoperative ComplicationsRecurrenceMitral valve annuloplastyMitral valve030212 general & internal medicineHospital MortalityHeart Valve Prosthesis ImplantationExercise ToleranceIschemic mitral regurgitationMitral Valve InsufficiencyGeneral MedicineMiddle Agedmedicine.anatomical_structureTreatment OutcomeItalyHeart Valve ProsthesisCardiologyMitral ValveFemaleCardiology and Cardiovascular MedicineArteryEchocardiography StressPulmonary and Respiratory Medicinemedicine.medical_specialtyProsthesis Design03 medical and health sciencesInternal medicinemedicine.arterymedicineHumansMitral AnnuloplastyAgedRetrospective StudiesMitral regurgitationbusiness.industryRecovery of FunctionSurgeryPulmonary arteryChronic DiseaseExercise TestSurgerybusinessSeminars in thoracic and cardiovascular surgery
researchProduct

Inhaled Prostacyclin, Nitric Oxide, and Nitroprusside in Pulmonary Hypertension After Mitral Valve Replacement

2005

Abstract Objective: Pulmonary hypertension increases morbidity and mortality in patients undergoing heart surgery. Mitral valve stenosis is frequently associated with an increase in pulmonary vascular resistance (PVR). Cardiopulmonary bypass exacerbates pulmonary hypertension in patients undergoing cardiac surgery. The aim of this study was to compare the hemodynamic effects of inhaled prostacyclin and nitric oxide and the administration of i.v. nitroprusside during cardiac surgery with a clinical, pharmacodynamic dose-response, prospective, randomized, and double-blind study (Group A: inhaled prostacyclin; Group B: inhaled nitric oxide; Group C: nitroprusside). Materials and Methods: Fifty…

MaleNitroprussidePulmonary and Respiratory Medicinemedicine.medical_specialtyCardiac outputHypertension Pulmonarymedicine.medical_treatmentProstacyclinNitric OxideNitric oxidechemistry.chemical_compoundMitral valve stenosisDouble-Blind MethodInternal medicineAdministration InhalationmedicineHumansMitral Valve StenosisAntihypertensive AgentsEndothelium-Dependent Relaxing FactorsHeart Valve Prosthesis ImplantationCardiopulmonary Bypassbusiness.industryMitral valve replacementMiddle Agedmedicine.diseaseEpoprostenolPulmonary hypertensionCardiac surgerymedicine.anatomical_structurechemistryAnesthesiacardiovascular systemCardiologyVascular resistanceMitral ValveFemaleSurgeryCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of Cardiac Surgery
researchProduct

Non-sutureless minimally invasive aortic valve replacement: mini-sternotomy versus mini-thoracotomy: a series of 1130 patients

2016

Objectives Aortic valve replacement through conventional sternotomy still represents the gold-standard surgical approach for aortic valve disease. However, given the increasing number of patients with comorbidities, strategies that can improve operative results are always sought. Minimally invasive aortic valve surgery, although related to a steep learning curve, might be associated with improved postoperative outcomes. The main aim of this study was to assess whether significant differences exist in terms of operative and early results between a mini-sternotomy and a right mini-thoracotomy approach for isolated aortic valve replacement without sutureless technologies. Methods This is an ob…

MalePulmonary and Respiratory MedicineAortic valveAortic valve replacement • Exposure • Incision • Minimally invasive surgery • Surgery • Techniquemedicine.medical_specialtymedicine.medical_treatmentHeart Valve Diseases030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineAortic valve replacementlawmedicineCardiopulmonary bypassHumansMinimally Invasive Surgical ProceduresThoracotomyAgedRetrospective StudiesHeart Valve Prosthesis Implantationbusiness.industrySuture TechniquesAortic valve disorderRetrospective cohort studymedicine.diseaseSternotomySurgerymedicine.anatomical_structureThoracotomy030228 respiratory systemAortic ValveHeart Valve ProsthesisAortic valve surgeryFemaleSurgeryObservational studyCardiology and Cardiovascular Medicinebusiness
researchProduct

Modified Danielson Technique for Prosthetic Aortic Valve Endocarditis and Aortoventricular Discontinuity

2020

Endocarditis is a devastating complication of prosthetic aortic valve replacement. The infective process can destroy aortic annulus tissue, making conventional surgical valve replacement difficult or impossible and causing aortoventricular discontinuity. Several treatment techniques have been proposed. One of these, the Danielson technique, involves translocating the aortic valve to the native ascending aorta, débriding the abscess cavity, closing the coronary ostia, and bypassing the coronary arteries with a Y anastomosis between 2 vein grafts. We describe our use of a modified Danielson technique in a 68-year-old man with advanced prosthetic valve endocarditis that was associated with aor…

MaleReoperationAortic valvemedicine.medical_specialtyProsthesis-Related Infectionsmedicine.medical_treatmentAnastomosisValve replacementAortic valve replacementmedicine.arteryAscending aortaHumansMedicineEndocarditisCardiac skeletonCardiac Surgical ProceduresAgedbusiness.industryEndocarditis Bacterialmedicine.diseaseTechniquesSurgeryCoronary arteriesmedicine.anatomical_structureEchocardiographyAortic ValveHeart Valve Prosthesiscardiovascular systemCardiology and Cardiovascular MedicinebusinessTexas Heart Institute Journal
researchProduct

Chronic Urticaria After Implantation of a Mitral Annuloplasty Ring in a Nickel-Allergic Patient

2017

MaleReoperationNickel allergymedicine.medical_specialtyMitral Valve AnnuloplastyUrticariaImmunology030204 cardiovascular system & hematologyProsthesis DesignImmunoglobulin E03 medical and health sciences0302 clinical medicineMitral annuloplasty ringDevice removalNickelMitral valve annuloplastyInternal medicineHumansImmunology and AllergyMedicineProsthesis designDevice RemovalChronic urticariaHeart Valve Prosthesis Implantationbiologybusiness.industryMiddle AgedPatch TestsSurgeryChronic diseaseHeart Valve ProsthesisChronic DiseaseDermatitis Allergic ContactCardiologybiology.proteinMitral Valvebusiness030217 neurology & neurosurgeryJournal of Investigational Allergology and Clinical Immunology
researchProduct

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normali…

2012

Subtherapeutic international normalized ratio (INR) is frequently encountered in clinical practice, and patients with high-risk atrial fibrillation (AF) and with mechanical heart valve (MHV) with inadequate anticoagulation may be exposed to an increased risk of thromboembolic events (TE). However, there are no prospective data evaluating this risk. Consecutive patients with a history of stable anticoagulation, but with a subtherapeutic INR, were prospectively included. Data on use and dose of low-molecular weight heparin (LMWH) bridging therapy were collected. The incidence of objectively confirmed TE and of major bleeding events within 90 days after the index INR was assessed. Five hundred…

MaleRiskmedicine.medical_specialtyPopulationvenous thromboembolismHemorrhageComorbidityThrombophiliaFollow-Up StudiePostoperative ComplicationsInternal medicineThromboembolismAtrial FibrillationmedicineHumansThrombophiliaProspective StudiesInternational Normalized RatioeducationProspective cohort studyAgedAged 80 and overHeart Valve Prosthesis Implantationeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceMedicine (all)WarfarinAnticoagulantAnticoagulantsAtrial fibrillationHematologyHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseConfidence intervalSurgeryProspective StudieHeart Valve ProsthesiHeart Valve ProsthesisFemalePostoperative ComplicationWarfarinbusinessCohort studymedicine.drugFollow-Up StudiesHuman
researchProduct

Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.

2002

Abstract Background: The aim of our study was to investigate the efficacy of the combination of clopidogrel and aspirin in the prevention of thrombus formation on artificial heart valves in an experimental rabbit model as compared to anticoagulation with warfarin. Methods: Studies were performed after oral administration of clopidogrel and aspirin in group I (n=9) for 5 days, after 5±2 days treatment with warfarin in group II (n=9) and without medication in group III (n=9). Leaflets from Sulzer Carbomedics bileaflet valves were placed in a flow chamber. The flow chamber was filled with blood in a continuous circulation between the carotid artery and the jugular vein. Results: In group III, …

MaleTiclopidineArtificial heart valveDrug Evaluation PreclinicalIn Vitro Techniquesmedicine.disease_causeJugular veinmedicineAnimalscardiovascular diseasesHeart valveThrombusAspirinAspirinbusiness.industryWarfarinThrombosisHematologymedicine.diseaseClopidogrelThrombosisClopidogrelMicroscopy Electronmedicine.anatomical_structureAnesthesiaHeart Valve Prosthesiscardiovascular systemDrug Therapy CombinationRabbitsWarfarinbusinessmedicine.drugThrombosis research
researchProduct